LEQEMBI (lecanemab)

**Product type:** Human Prescription Drug

**Active ingredient:** LECANEMAB

**Strength:** 100 mg/mL

**Dosage form:** Injection, Solution

**Route:** Intravenous

**Labeler:** Eisai Inc.

**Marketing category:** BLA (BLA761269)

**Pharmacologic class:** Amyloid Beta-directed Antibody Interactions [MoA], Amyloid Beta-directed Antibody [EPC]